Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma

[1]  Edward Kim,et al.  Radiation Segmentectomy , 2021, Seminars in Interventional Radiology.

[2]  R. Salem,et al.  Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study , 2021, Hepatology.

[3]  A. Kamath,et al.  A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. , 2021, Surgery.

[4]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[5]  R. Salem,et al.  Contemporary Techniques and Applications of Radioembolization in Patients with Hepatocellular Carcinoma , 2020 .

[6]  D. Ganger,et al.  Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐Year Experience in 207‐Patient Cohort , 2020, Hepatology.

[7]  R. Salem,et al.  Modified Radiation Lobectomy: An Evolving Paradigm to Convert Patients to Liver Resection Candidacy , 2019, Seminars in Interventional Radiology.

[8]  C. Moulton,et al.  Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  R. Salem,et al.  Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma. , 2019, Seminars in nuclear medicine.

[10]  M. Abecassis,et al.  Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. , 2018, Journal of vascular and interventional radiology : JVIR.

[11]  A. Benson,et al.  Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience , 2018, Hepatology.

[12]  F. Miller,et al.  Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma , 2018, Abdominal Radiology.

[13]  M. Abecassis,et al.  Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma. , 2018, Radiology.

[14]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[15]  P. Lucatelli,et al.  Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review. , 2017, Translational gastroenterology and hepatology.

[16]  J. Theysohn,et al.  Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma , 2017, Clinical transplantation.

[17]  S. Kwan,et al.  Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. , 2017, Journal of vascular and interventional radiology : JVIR.

[18]  J. Theysohn,et al.  Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment , 2017, Annals of transplantation.

[19]  M. G. Doherty,et al.  Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis , 2017, Annals of Surgical Oncology.

[20]  A. Rademaker,et al.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[21]  J. Bruix,et al.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.

[22]  A. Maker,et al.  Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis , 2016, Journal of Gastrointestinal Surgery.

[23]  B. Goh,et al.  Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization? , 2015, World journal of gastroenterology.

[24]  M. Abecassis,et al.  90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes , 2015, Journal of surgical oncology.

[25]  L. Henry,et al.  Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up , 2015, Annals of Surgical Oncology.

[26]  M. Abecassis,et al.  Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy , 2014, Hepatology.

[27]  S. Kwan,et al.  Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity. , 2014, Journal of vascular and interventional radiology : JVIR.

[28]  M. Abecassis,et al.  Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.

[29]  A. Tsung,et al.  Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. , 2013, Journal of vascular and interventional radiology : JVIR.

[30]  B. Sangro,et al.  Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[31]  M. Colasanti,et al.  Experiences in Hepatic Surgery and Transplantation after Radioembolization , 2011 .

[32]  M. Mulcahy,et al.  Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. , 2009, Journal of vascular and interventional radiology : JVIR.

[33]  M. Abecassis,et al.  A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  V. Pamecha,et al.  Effect of portal vein embolisation on the growth rate of colorectal liver metastases , 2009, British Journal of Cancer.

[36]  F. Miller,et al.  Biliary sequelae following radioembolization with Yttrium-90 microspheres. , 2008, Journal of vascular and interventional radiology : JVIR.

[37]  N. Habib,et al.  Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis , 2008, Annals of surgery.

[38]  T. Aikou,et al.  Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization , 2007, Acta radiologica.

[39]  M. Abecassis,et al.  Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.

[40]  Kenneth G. Thurston,et al.  Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. , 2006, Journal of vascular and interventional radiology : JVIR.

[41]  Kenneth G. Thurston,et al.  Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. , 2006, Journal of vascular and interventional radiology : JVIR.

[42]  R. Salem,et al.  Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation , 2006, Journal of Gastrointestinal Surgery.

[43]  M. Abecassis,et al.  Use of yttrium‐90 microspheres (TheraSphere®) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[44]  J. Vauthey,et al.  Preoperative Portal Vein Embolization for Extended Hepatectomy , 2003, Annals of surgery.

[45]  V. Vilgrain,et al.  Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial , 2003, Annals of surgery.

[46]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[47]  W. Lau,et al.  Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma , 2001, Annals of surgery.

[48]  Y. Ikeda,et al.  Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[49]  E. Ntzani,et al.  The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[50]  Y 90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma , 2017 .

[51]  R. Golfieri,et al.  Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation , 2016, World Journal of Surgery.

[52]  A. Benson,et al.  Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. , 2011, International journal of radiation oncology, biology, physics.

[53]  A. Benson,et al.  Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.

[54]  J. Wong,et al.  The surgical management of primary carcinoma of the liver , 2005, World Journal of Surgery.

[55]  ndrea,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[56]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[57]  W. Ensminger,et al.  Clinical pharmacology of hepatic arterial chemotherapy. , 1983, Seminars in oncology.